- Report
- April 2026
- 179 Pages
Global
From €5169EUR$5,850USD£4,474GBP
- Report
- May 2025
- 106 Pages
Global
From €4197EUR$4,750USD£3,633GBP
- Report
- November 2023
- 30 Pages
Global
From €2430EUR$2,750USD£2,103GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 80 Pages
Europe
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Germany
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Italy
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Oman
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Egypt
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
United Kingdom
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
France
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Saudi Arabia
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Mexico
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Russia
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Japan
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 90 Pages
South Korea
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4197EUR$4,750USD£3,633GBP
- Report
- February 2024
- 70 Pages
India
From €4197EUR$4,750USD£3,633GBP

Levemir is a medication used to treat endocrine and metabolic disorders, such as diabetes. It is a long-acting insulin analog, meaning it is a synthetic form of insulin that is designed to mimic the body's natural insulin production. Levemir is used to control blood sugar levels in people with type 1 and type 2 diabetes. It is typically taken once or twice daily, depending on the individual's needs. Levemir is available in both vials and pens, and is typically injected under the skin.
Levemir is a popular medication for treating endocrine and metabolic disorders, and is widely available in many countries. It is manufactured by Novo Nordisk, a Danish pharmaceutical company, and is available in both generic and branded forms. Other companies that produce Levemir include Sanofi, Eli Lilly, and Biocon. Show Less Read more